Connect with us

Stock News

Ascendis Pharma’s stock surges after FDA approval for first and only treatment for rare disease

Published

on


The stock of Ascendis Pharma A/S jumped 11% early Monday, after the biotech said the U.S. Food and Drug Administration has approved its Yorvipath as the first and only treatment for a rare endocrine disease.

Continue Reading

Stock News

Treasury yields trim declines after PCE inflation reading edges up from Fed’s target

Published

on

Treasury yields were trimming earlier declines after a barrage of pre-Thanksgiving economic data added to the case for gradual Fed rate cuts .

Continue Reading

Stock News

Jobless claims slide to 7-month low. Businesses not cutting many jobs.

Published

on


The number of Americans who applied for unemployment benefits in the week before the Thanksgiving holiday dipped to a seven-month low in a sign of strength for a steadily expanding U.S. economy.

Continue Reading

Stock News

More turnover at the top, but this bull still believes in the Weight Watchers parent

Published

on


D.A. Davidson reckons WW is a buy as its customers need more than a prescription.

Continue Reading

Trending